You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 28, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Hojjat Ahmadzadehfar1, Harun Ilhan2,3, Marnix G E H Lam4
1Nuclear Medicine, Klinikum Westfalen GmbH, Dortmund, Germany.
Radioembolization uses radionuclide microspheres to treat liver tumors. This review covers therapy planning, dosimetry, and indications for 90Y-glass, resin microspheres, and 166Ho-microspheres.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: